SOURCE: Cleveland BioLabs, Inc.

August 28, 2007 10:41 ET

Cleveland BioLabs to Present at Roth Capital Partners 2007 New York Conference

BUFFALO, NY--(Marketwire - August 28, 2007) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) (BOST: CBLI) today announced that the Company is scheduled to present at the Roth Capital Partners 2007 New York Conference, September 5-6, 2007, in New York, NY.

Michael Fonstein, Ph.D., President and Chief Executive Officer of Cleveland BioLabs, will give a presentation on the Company, followed by a question and answer session on September 6, at 2:00 p.m. ET. The presentation will be broadcast live over the Internet via the Company's website at www.cbiolabs.com or at http://www.wsw.com/webcast/roth13/cald/.

Management will be available for investor meetings in New York on September 5-6, 2007.

About Cleveland BioLabs, Inc.

Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic Foundation, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Research Radiobiology Institute. To learn more about Cleveland BioLabs Inc., please visit the company's website at http://www.cbiolabs.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Some of the factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in our filings with the Securities and Exchange Commission.

Contact Information

  • Contact:
    The Global Consulting Group
    Rachel Levine
    T: (646) 284-9439
    E: Email Contact